EQL Pharma Investor Relations

Raymond de Vre

Board member

Education

MSc and PhD in Applied Physics from Stanford University and a master’s degree in engineering from Université Libre de Bruxelles.

Born

1968

Shareholding

None

Independent

Yes

Assumed

Board member since 2025

Professional experience

Managing Director at RADV Advisory GmbH and non-executive board member at Codexis Inc. Prior, he was the CEO of PolyPeptide Group AG and a Partner at McKinsey & Company.